Cost burden and treatment patterns associated with management of heavy menstrual bleeding

Journal of Women's Health

Volumn 21, Issue 5, 2012, Pages 539-547

  Jensen, Jeffrey T ^a   Lefebvre, Patrick ^b   Laliberté, François ^b   Sarda, Sujata P ^b   Law, Amy ^c   Pocoski, Jennifer ^c   Duh, Mei Sheng ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b ANALYSIS GROUP   (United States)

^c BAYER CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; GESTAGEN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE;

ADULT; ARTICLE; CONTROLLED STUDY; COST UTILITY ANALYSIS; CURETTAGE; EMERGENCY CARE; ENDOMETRIUM ABLATION; FEMALE; FOLLOW UP; HEALTH CARE COST; HEAVY MENSTRUAL BLEEDING; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; MENSTRUATION; MENSTRUATION DISORDER; OUTPATIENT CARE; PRIORITY JOURNAL; VAGINA RING;

ADOLESCENT; ADULT; COST OF ILLNESS; COSTS AND COST ANALYSIS; DRUG UTILIZATION REVIEW; FEMALE; FOLLOW-UP STUDIES; HEALTH BENEFIT PLANS, EMPLOYEE; HEALTH SERVICES; HOSPITALIZATION; HUMANS; INSURANCE COVERAGE; INSURANCE, DISABILITY; INTERNATIONAL CLASSIFICATION OF DISEASES; LONGITUDINAL STUDIES; MENORRHAGIA; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UNITED STATES;

EID: 84862228791     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2011.3147     Document Type: Article

References (42)

1. Fraser IS, Critchley HO, Munro MG, Broder MS. A process designed to lead to international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding. Fertil Steril 2007;87:466-476. (Pubitemid 46385988)
2. Woolcock JG, Critchley HO, Munro MG, Broder MS, Fraser IS. Review of the confusion in current and historical terminology and definitions for disturbances of menstrual bleeding. Fertil Steril 2008;90:2269-2280.
3. Hallberg L, Högdahl AM, Nilsson L, Rybo G. Menstrual blood loss-A population study. Variation at different ages and attempts to define normality. Acta Obstet Gynecol Scand 1996;45:320-351.
4. Cole SK, Billewicz WZ, Thomson AM. Sources of variation in menstrual blood loss. J Obstet Gynaecol Br Commonw 1971; 78:933-939.
5. Côté I, Jacobs P, Cumming DC. Use of health services associated with increased menstrual loss in the United States. Am J Obstet Gynecol 2003;188:343-348. (Pubitemid 36249968)
6. Gath D, Osborn M, Bungay G, et al. Psychiatric disorder and gynaecological symptoms in middle aged women: A community survey. BMJ Clin Res Ed 1987;294:213-218. (Pubitemid 17231391)
7. Wyatt KM, Dimmock PW, Walker TJ, O'Brien PM. Determination of total menstrual blood loss. Fertil Steril 2001; 76:125-131. (Pubitemid 32600969)
8. Reid PC, Coker A, Coltart R. Assessment of menstrual blood loss using a pictorial chart: A validation study. Br J Obstet Gynaecol 2000;107:320-322. (Pubitemid 30145371)
9. Cooper KG, Parkin DE, Garrett A, et al. A randomized comparison of medical and hysteroscopic management in women consulting a gynaecologist for treatment of heavy menstrual loss. Br J Obstet Gynaecol 1997;104:1360-1366. (Pubitemid 27517632)
10. Vilos GA, Lefebvre G, Graves GR. Guidelines for the management of abnormal uterine bleeding. J Obstet Gynaecol Can 2001;23:704-709.
11. Albers JR, Hull SK, Wesley MA. Abnormal uterine bleeding. Am Fam Physician 2004;69:1915-1926.
12. Kilbourn CL, Richards CS. Abnormal uterine bleeding. Diagnostic considerations, management options. Postgrad Med 2001;109:137-138, 141-144, 147-150.
13. Oriel KA, Schrager S. Abnormal uterine bleeding. Am Fam Physician 1999;60:1371-1382. (Pubitemid 29498204)
14. Working Party for Guidelines for the Management of Heavy Menstrual Bleeding. An evidence-based guideline for the management of heavy menstrual bleeding. NZ Med J 1999; 112:174-177.
15. Bongers MY, Mol BW, Brolmann HA. Current treatment of dysfunctional uterine bleeding. Maturitas 2004;47:159-174. (Pubitemid 38270394)
16. Ely JW, Kennedy CM, Clark EC, Bowdler NC. Abnormal uterine bleeding: A management algorithm. J Am Board Fam Med 2006;19:590-602. (Pubitemid 44736814)
17. American College of Obstetricians and Gynecologists Committee on Practice Bulletins. Gynecology. Management of anovulatory bleeding. Int J Gynecol Obstet 2001;72: 263-271.
18. Royal College of Obstetricians and Gynaecologists. Guidelines- Menorrhagia. Available at www.gp-training.net/protocol/gynaecology/menorrhagia/ menorrhagia-rcog.htm Accessed April 25, 2011.
19. Roy SN, Bhattacharya S. Benefits and risks of pharmacological agents used for the treatment of menorrhagia. Drug Saf 2004;27:75-90. (Pubitemid 38186951)
20. Lethaby A, Augood C, Duckitt K, Farquhar C. Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding. Cochrane Database Syst Rev 2007;4:CD000400.
21. Lethaby A, Farquhar C, Cooke I. Antifibrinolytics for heavy menstrual bleeding. Cochrane Database Syst Rev 2000;4: CD000249.
22. Lethaby A, Irvine GA, Cameron IT. Cyclical progestogens for heavy menstrual bleeding. Cochrane Database Syst Rev 2008;1:CD001016.
23. Prentice A. Fortnightly review. Medical management of menorrhagia. BMJ 1999;319:1343-1345. (Pubitemid 29537507)
24. Kaunitz AM, Meredith S, Inki P, Kubba A, Sanchez-Ramos L. Levonorgestrel-releasing intrauterine system and endometrial ablation in heavy menstrual bleeding: A systematic review and meta-analysis. Obstet Gynecol 2009;113:1104-1106.
25. Hurskainen R, Teperi J, Rissanen P, et al. Clinical outcomes and costs with the levornorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: Randomized trial 5-year follow-up. JAMA 2004;291:1456-1563.
26. Cooper KG, Jack SA, Parkin DE, Gran AM. Five-year followup of women randomized to medical management or transcervical resection of the endometrium for heavy menstrual loss: Clinical and quality of life outcomes. Br J Obstet Gynaecol 2001;108:1222-1228. (Pubitemid 34076732)
27. Cooper KG, Parkin DE, Garratt AM, Grant AM. Two-year follow-up of women randomized to medical management or transcervical resection of the endometrium for heavy menstrual loss: Clinical and quality of life outcomes. Br J Obstet Gynaecol 1999;106:258-265. (Pubitemid 29118913)
28. Goodman A. Abnormal genital tract bleeding. Clin Cornerstone 2000;3:25-35.
29. Liu Z, Doan QV, Blumenthal P, Dubois RW. A systematic review evaluating health-related quality of life, work impairment, and health-care costs and utilization in abnormal uterine bleeding. Value Health 2007;10:183-194. (Pubitemid 46802276)
30. Côté I, Jacobs P, Cumming DC. Work loss associated with increased menstrual loss in the United States. Obstet Gynecol 2002;100:683-687. (Pubitemid 35300023)
31. Munro MG, Critchley HOD, Fraser IS. The FIGO classification of causes of abnormal uterine bleeding in the reproductive years. Fertil Steril 2011;95:2204-2208.
32. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a nonrandomized control group. Stat Med 1998;17:2265-2281. (Pubitemid 28466823)
33. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987;40:373-383. (Pubitemid 17055592)
34. Chi C, Huq FY, Kadir RA. Levornorgestrel-releasing intrauterine system for the management of heavy menstrual bleeding in women with inherited bleeding disorders: Longterm follow-up. Contraception 2011;83:242-247.
35. Blumenthal PD, Dawson L, Hurskainen R. Cost-effectiveness and quality of life associated with heavy menstrual bleeding among women using the levonorgestrel-releasing intrauterine system. Int J Gynaecol Obstet 2011;112:171-178.
36. FDA approves additional use for IUD Mirena to treat heavy menstrual bleeding in IUD users. Available at www.fda .gov/NewsEvents/Newsroom/ PressAnnouncements/2009/ucm184747.htm Accessed April 25, 2011.
37. Shapley M, Jordan K, Croft PR. An investigation in primary care of the relationship between consultation behavior, increased vaginal bleeding and mental disorder. J Obstet Gynecol 2004;24:684-686. (Pubitemid 39655430)
38. Doherty L, Harper A, Russell M. Menorrhagia management options. Ulster Med J 1995;64:64-71.
39. Gozzard D. When is high-dose intravenous iron repletion needed? Assessing new treatment options. Drug Design Dev Ther 2011;5:51-60.
40. Morrison J, Patel ST, Watson W, Zaidi QR, Mangione A, Goss TF. Assessment of the prevalence and impact of anemia on women hospitalized for gynecologic conditions associated with heavy uterine bleeding. J Reprod Med 2008;53: 323-330. (Pubitemid 351846376)
41. Farell E. Dysfunctional uterine bleeding. Aus Fam Physician. 2004;33:906-908.
42. Lukes AS, Kadir RA, Peyvandi F, Kouides PA. Disorders of hemostasis and excessive menstrual bleeding: Prevalence and clinical impact. Fertil Steril 2005;84:1338-1344. (Pubitemid 41571879)